SARAH MARSHALL: Open Payments
NPI 1588218119 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 11 payments from 8 companies in 2025. Trend: 2023 $46 · 2024 $166 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $59 |
| UCB, Inc. | 2 | $56 |
| Octapharma USA, Inc. | 1 | $24 |
| Melinta Therapeutics, LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Eisai Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Rystiggo, OCTAGAM IMMUNE GLOBULIN (HUMAN), KISUNLA, Cimzia, Rezzayo, SPEVIGO, EVENITY, AMYVID.
Industry payments across TN — which companies pay providers there.
